SOCS2-AS1 exerted its tumor-suppressive activity through interaction with and promotion of AURKA ubiquitin degradation, thereby reducing the levels of AURKA protein and its target mRNAs—including those mRNAs directly associated with cancer cell growth. This evidence concerns the gene SOCS2 and cancer.